|
시장보고서
상품코드
2109018
페이스메이커/제세동기 전극선 제거 키트 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)Pacemaker/Defibrillator Lead Extraction Kit - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
심박조율기/제세동기 리드 제거 키트란, 전기생리학자나 심장외과 의사가 감염, 파손, 기능 부전, 혹은 임상적으로 더 이상 필요하지 않게 된, 장기간 이식된 심박조율기, 이식형 제세동기(ICD), 심장 재동기화 치료(CRT)(CRT)용 리드를 제거하기 위해 사용하는 경피적 시술용 전용 기구 세트입니다. 장기간 이식된 리드는 치밀한 섬유 조직에 둘러싸여 있고, 혈관이나 심장 구조물에 유착되어 있기 때문에 단순한 수동 견인만으로는 불충분한 경우가 많아, 의사는 잠금식 스타일렛, 신축식 시스, 기계식 또는 동력식(레이저 또는 고주파) 에너지를 이용하여 유착 부위를 박리하고, 리드를 분리하여 안전하게 적출하고 있습니다. 시장은 제품 유형별(전체 시스템)로 분류되며, 기계식 적출 시스템 및 동력식 적출 시스템, 그리고 로킹 스타일렛, 시스, 카운터 트랙션 디바이스 등의 부속품으로 구성되어 있습니다. 또한, 최종 사용자별로는 병원 및 전문 심장 클리닉으로 분류됩니다. CIED 이식 건수 증가, 기기 관련 감염 발생률의 상승, 조기 및 완전한 하드웨어 제거를 권장하는 전문가들의 합의 지침, 그리고 에너지 보조형 제거 도구의 지속적인 혁신에 힘입어, 심박조율기/제세동기 리드 제거 키트는 경정맥적 리드 관리 과정에서 필수적인 수단이 되었습니다.
심박조율기/제세동기 리드 제거 키트 시장의 주요 성장 요인
심박조율기/제세동기 리드 제거 키트 시장의 성장에 기여하는 요인
시장 성장 촉진요인
심장용 이식형 전자 기기의 전 세계적 부담 증가
심박조율기/제세동기 리드 제거 키트 시장의 가장 근본적인 촉진요인은 심박조율기, ICD 및 CRT의 이식이 전 세계적으로 꾸준히 증가하고 있다는 점입니다. 새로 이식된 리드는 수년에 걸친 체내 잔류 기간을 거친 후, 결국 교체, 업그레이드 또는 제거 대상이 되기 때문에 누적 이식 건수는 제거 대상 환자 수를 직접적으로 확대시킵니다. 기기의 수명이 연장되고, 환자가 여러 개의 리드를 체내에 남긴 채 장수함에 따라, 방치되거나 파손되었거나 기능적으로 노후화된 하드웨어의 유병률도 함께 상승하고 있습니다. 전기생리학 프로그램에서는 2개 이상의 리드가 장기간 체내에 삽입된 채로 남아 있어, 심장 재동기화 치료나 리드리스 심박조율기 시스템으로의 기기 업그레이드가 필요한 환자를 접하는 사례가 증가하고 있습니다. 어느 경우든 우선 기존 하드웨어를 제거해야 할 가능성이 있습니다. 이처럼 지속적으로 증가하는 이식형 리드 기반이 예측 기간 동안 전용 제거 툴킷에 대한 견고하고 장기적인 수요를 뒷받침하고 있습니다.
CIED 관련 감염 발생률 증가
기기 관련 감염은 리드 제거의 가장 중요한 임상적 요인이며, 합의 지침에서는 감염이 확인된 경우 하드웨어의 완전한 제거를 클래스 I 권고 사항으로 규정하고 있습니다. 집단 수준의 데이터에 따르면, CIED 이식 환자의 약 1.1%가 장기 추적 조사 기간 동안 기기 관련 감염을 발병했으며, 이후 제너레이터 교체나 리드 재이식을 할 때마다 감염 위험이 크게 높아집니다. 유럽 19개국 73개 기관에서 3,500명 이상의 환자를 등록한 대규모 다국적 레지스트리 ‘ELECTRa’에 따르면, 감염은 리드 기능 부전이나 비감염성 업그레이드 필요성과 함께 경정맥적 리드 제거의 주요 적응증으로 계속 남아 있는 것으로 밝혀졌습니다. 전 세계적으로 이식형 기기의 총 수가 증가하고, 반복적인 시술을 받는 환자가 늘어남에 따라 기기 감염으로 인한 누적 부담 및 이에 따른 제거 건수는 2034년까지 꾸준히 증가할 것으로 예측됩니다.
시장 제약 요인
견고한 기초 성장 모멘텀에도 불구하고, 심박조율기/제세동기 리드 제거 키트 시장은 중대한 제약에 직면해 있습니다. 리드 제거는 본질적으로 고위험 시술이며, 상대정맥 파열이나 심장 탐포네이드 등 드물지만 치명적인 합병증을 유발할 가능성이 있기 때문에 병원은 즉시 수술에 대응할 수 있는 체계와 다학제 팀을 유지해야 합니다. 이 때문에 시술은 대규모의 충분한 자원을 갖춘 시설에 집중되어 더 광범위한 보급이 제한되고 있습니다. 전동 레이저 제거 시스템은 막대한 초기 설비 투자, 정기적인 교정 및 유지보수 계약이 필요하며, 특히 비용에 민감한 신흥 시장에서 소규모 병원이나 전문 클리닉의 경우 도입 장벽이 될 수 있습니다. 경정맥 리드 제거에 대한 정식 훈련을 받은 의사의 만성적인 부족은 임상적 필요성이 존재하더라도 시술 건수를 제한하고 있으며, 연구에 따르면 제거 시술을 수행하는 병원의 대다수는 연간 시술 건수가 적어, 이는 치료 성과 저하와 관련이 있습니다. 리드 제거 시술 및 전용 툴킷에 대한 보험 환급은 지역에 따라 여전히 불균형하며, 새로운 에너지 기반 제거 기술에 대한 엄격한 규제 승인 요건이 시장 출시까지의 기간을 길게 만들 가능성이 있습니다. 이러한 자본, 교육, 안전성 및 보험 환급과 관련된 장벽들이 복합적으로 작용하여, CIED 이식 건수 증가, 감염 부담, 지침에 따른 수요와 같은 근본적인 요인들이 여전히 견고하게 존재함에도 불구하고 도입 속도를 둔화시키고 있습니다.
Pacemaker/Defibrillator Lead Extraction Kit Market Summary
A pacemaker/defibrillator lead extraction kit is a specialized set of percutaneous tools used by electrophysiologists and cardiac surgeons to remove chronically implanted pacemaker, implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT) leads that have become infected, fractured, malfunctioning, or clinically unnecessary. Because chronically implanted leads become encased in dense fibrous tissue and adherent to vascular and cardiac structures, simple manual traction is frequently insufficient, and physicians rely on locking stylets, telescoping sheaths, and either mechanical or powered (laser or radiofrequency) energy to dissect binding sites and free the lead for safe removal. The market is organized by product type across systems, comprising mechanical extraction systems and powered extraction systems, and accessories such as locking stylets, sheaths, and counter-traction devices; and by end-user across hospitals and specialty cardiac clinics. Driven by rising CIED implantation volumes, growing device-related infection rates, expert-consensus guidance favoring early and complete hardware removal, and continued innovation in energy-assisted extraction tools, pacemaker/defibrillator lead extraction kits have become an essential capability within the transvenous lead management pathway.
Pacemaker/Defibrillator Lead Extraction Kit Market Key Growth Drivers
Key Companies in Pacemaker/Defibrillator Lead Extraction Kit Market
The competitive landscape is led by the following active manufacturers:
Factors Contributing to the Growth of the Pacemaker/Defibrillator Lead Extraction Kit Market
Market Drivers
Rising Global Burden of Cardiac Implantable Electronic Devices
The most fundamental driver of the Pacemaker/Defibrillator Lead Extraction Kit market is the steady worldwide growth in pacemaker, ICD, and CRT implantation. Every newly implanted lead becomes, over its multi-year dwell time, a candidate for eventual revision, upgrade, or extraction, so cumulative implant volume directly expands the addressable extraction population. As device longevity extends and patients live longer with multiple leads, the prevalence of abandoned, fractured, or functionally obsolete hardware rises in parallel. Electrophysiology programs are increasingly encountering patients with two or more chronically implanted leads requiring a device upgrade to cardiac resynchronization therapy or a leadless pacing system, each of which may first require extraction of existing hardware. This growing base of implanted leads anchors durable, multi-year demand for dedicated extraction tool kits across the forecast period.
Increasing Incidence of CIED-Related Infections
Device-related infection is the single most important clinical driver of lead extraction, and consensus guidelines classify complete hardware removal as a Class I recommendation whenever infection is confirmed. Population-level data indicate that roughly 1.1% of CIED recipients develop a device infection over long-term follow-up, and infection risk rises substantially with each subsequent generator change or lead revision. The large multinational ELECTRa registry, which enrolled over 3,500 patients across 73 centers in 19 European countries, documented that infection remains a leading indication for transvenous lead extraction, alongside lead malfunction and non-infectious upgrade needs. As the global inventory of implanted devices grows and more patients undergo repeat procedures, the cumulative burden of device infection and the corresponding extraction volume is expected to increase steadily through 2034.
Market Restraints
Despite strong underlying momentum, the Pacemaker/Defibrillator Lead Extraction Kit market faces material constraints. Lead extraction remains an inherently high-risk procedure, with rare but potentially fatal complications such as superior vena cava tears and cardiac tamponade, so hospitals must maintain immediate surgical backup and a multidisciplinary team, which concentrates procedures among larger, well-resourced centers and limits broader adoption. Powered laser extraction systems require significant upfront capital investment, periodic calibration, and service contracts that can be prohibitive for smaller hospitals and specialty clinics, particularly in cost-sensitive and emerging markets. A persistent shortage of physicians formally trained in transvenous lead extraction constrains procedural volumes even where clinical need exists, and studies show that a majority of hospitals performing extraction do so at low annual volumes, which is associated with inferior outcomes. Reimbursement for lead extraction procedures and dedicated tool kits remains uneven across geographies, and stringent regulatory clearance requirements for novel energy-based extraction technologies can lengthen time to market. Together, these capital, training, safety, and reimbursement barriers temper the pace of adoption, even as the underlying drivers of rising CIED implantation, infection burden, and guideline-driven demand remain firmly intact.
Pacemaker/Defibrillator Lead Extraction Kit Market Segment Analysis
The pacemaker/defibrillator lead extraction kit market by product type (system [mechanical extraction system, powered extraction system] and accessories), end-user (hospitals and specialty cardiac clinics), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Mechanical Extraction System.
The mechanical extraction system segment accounted for 46% of the Pacemaker/Defibrillator Lead Extraction Kit market in 2025. Mechanical extraction systems, such as flexible rotating dilator sheath sets, are the leading product type because they require no capital equipment, electricity, or annual maintenance contracts, giving hospitals of nearly any size an economical entry point into percutaneous lead extraction. Their hand- or motor-driven rotational mechanism allows the operator to feel progress through fibrous binding sites, and a single sheath set can extract multiple leads of the same diameter from one patient, reducing per-procedure device cost. Published multicenter experience with contemporary bidirectional mechanical sheaths reports complete lead removal rates around 97% and clinical success rates approaching 99%, reinforcing physician confidence. Systems as a category, encompassing both mechanical and powered extraction platforms, comprise the substantial majority of category revenue, while accessories such as locking stylets, counter-traction devices, and compression coils support nearly every procedure regardless of the primary extraction tool selected. While powered extraction systems are the fastest-growing product type, propelled by their efficiency in dense, long-dwell-time fibrosis, the affordability, simplicity, and broad installed base of mechanical systems secure the segment's leadership across the forecast period.
By End-Users
Dominant Subsegment: Hospitals.
The hospitals segment accounted for 85% of the Pacemaker/Defibrillator Lead Extraction Kit market in 2025. Hospitals are the leading end-user because lead extraction is classified as a high-risk procedure that requires immediate access to cardiac surgical backup, a hybrid operating room or catheterization laboratory equipped for emergency sternotomy, and a multidisciplinary team spanning electrophysiology, cardiac surgery, and anesthesiology. Consensus guidelines explicitly recommend that extraction be performed only at centers capable of managing major vascular or cardiac complications, which concentrates procedure volumes, and therefore kit purchasing, among hospitals rather than outpatient or ambulatory settings. Large academic and tertiary hospitals with high annual extraction volumes are also associated with superior outcomes and lower mortality, encouraging further procedural consolidation within the hospital setting. Specialty cardiac clinics are the fastest-growing end-user as select high-volume, well-resourced cardiac centers build dedicated lead management programs with on-site surgical support, but the safety requirements and infrastructure intensity of the procedure keep hospitals the dominant end-user across the forecast period.
Pacemaker/Defibrillator Lead Extraction Kit Market Region Analysis
Dominant Region: North America
North America accounted for 44% of the global Pacemaker/Defibrillator Lead Extraction Kit market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high per-capita rate of pacemaker and ICD implantation, a mature network of high-volume electrophysiology centers, well-established reimbursement pathways, and the concentrated presence of leading extraction device manufacturers. The United States hosts a dense base of hospitals with dedicated lead management programs and cardiac surgical backup, supporting broad adoption of both mechanical and powered extraction systems. Rising CIED-related infection rates, an aging population with a growing burden of arrhythmia and heart failure, and continued clinical education aligned with updated HRS and multi-society consensus guidance are sustaining strong procedural and device demand. Strong reimbursement, regulatory clarity from the FDA, and proximity to leading device manufacturers anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Pacemaker/Defibrillator Lead Extraction Kit market. The region's elevated CAGR is driven by rapidly rising CIED implantation volumes, expanding electrophysiology infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding its base of tertiary cardiac centers capable of performing complex extraction procedures, Japan's aging population is sustaining high rates of device implantation and eventual lead revision, and India is emerging as a lower-cost manufacturing and clinical-training hub for percutaneous cardiac procedures. Rising awareness of device-related infection management, growing government healthcare investment, and the gradual build-out of hybrid operating rooms with surgical backup are accelerating adoption of dedicated extraction kits across the region's higher-volume hospitals. The combination of rising disease burden, expanding device implantation, and improving procedural infrastructure positions Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 44% of the global Pacemaker/Defibrillator Lead Extraction Kit market revenue in 2025. The United States dominates on the strength of its high CIED implantation base, dense network of high-volume extraction centers, FDA regulatory clarity, and the concentrated presence of leading mechanical and powered extraction device manufacturers, while growing device infection rates and system-upgrade volumes reinforce its leadership.
Europe
Europe is a large and advanced regional market, supported by an established multinational extraction registry infrastructure exemplified by the ELECTRa study, harmonized regulatory pathways under the EU Medical Device Regulation, and a well-developed base of high-volume electrophysiology centers across Germany, France, the United Kingdom, Italy, and Spain. Continued adoption of both laser and mechanical extraction platforms, alongside growing clinical publication activity on extraction outcomes, reinforces the region's role in supplying both diagnostic and therapeutic lead management programs.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising CIED implantation, expanding tertiary cardiac care infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's tertiary cardiac center build-out, Japan's aging-population-driven device volumes, and India's expanding low-cost manufacturing and clinical-training base are accelerating regional adoption of dedicated lead extraction kits.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding cardiac care infrastructure, rising CIED implantation rates, and efforts to build dedicated electrophysiology and surgical-backup capability are gradually broadening access to safe percutaneous lead extraction, while training partnerships with established international centers support the build-out of regional procedural capacity.
Pacemaker/Defibrillator Lead Extraction Kit Market Competitive Landscape
The Pacemaker/Defibrillator Lead Extraction Kit market is classified as Moderately Concentrated. Established players with broad, clinically validated product portfolios, including Koninklijke Philips N.V. and Cook Medical, anchor the top tier through decades of clinical evidence and global distribution reach, while specialized and fast-scaling providers such as INVAMED compete through differentiated mechanical and laser platforms, and clinical-stage innovators such as Xtrac O.S. pursue novel, non-thermal extraction technologies, increasing competitive intensity in the powered and next-generation segments.
The competitive landscape can be evaluated across the following dimensions:
Pacemaker/Defibrillator Lead Extraction Kit Market Recent Developmental Activities
In 2026, Koninklijke Philips N.V. continued to expand its Image-Guided Therapy lead management portfolio, reinforcing adoption of its GlideLight laser sheath, which offers adjustable pulse repetition rate to improve advancement efficiency through dense binding sites, and its TightRail and TightRail Sub-C flexible mechanical rotating dilator sheaths designed for tortuous and subclavian vasculature. Strategic significance: Strengthens Philips' position as an integrated provider of both powered and mechanical extraction platforms.
In 2026, Cook Medical continued to broaden its Lead Management portfolio around the Evolution RL and Evolution Shortie RL controlled-rotation dilator sheath sets, alongside the SteadySheath Evolution tissue stabilization sheath and OneTie compression coil used to manage tenacious fibrosis-anchored leads. Strategic significance: Reinforces Cook's long-standing leadership in mechanical, capital-equipment-free lead extraction technology.
Pacemaker/Defibrillator Lead Extraction Kit Market Segmentation
Pacemaker/Defibrillator Lead Extraction Kit Market by Product Type
Pacemaker/Defibrillator Lead Extraction Kit Market by End-Users
Pacemaker/Defibrillator Lead Extraction Kit Market by Geography
Key Takeaways from the Pacemaker/Defibrillator Lead Extraction Kit Market Report Study
Target audience who can benefit from this pacemaker/defibrillator lead extraction kit market report study
Q1. What is the growth rate of the pacemaker/defibrillator lead extraction kit market?
The pacemaker/defibrillator lead extraction kit market is projected to expand at a CAGR of 7.2% during the forecast period from 2026-2034.
Q2. What is the market size of the pacemaker/defibrillator lead extraction kit market?
The pacemaker/defibrillator lead extraction kit market is estimated at USD 1.03 billion in 2025 and is projected to reach USD 1.92 billion by 2034.
Q3. Which region dominates the pacemaker/defibrillator lead extraction kit market?
North America dominated the Pacemaker/Defibrillator Lead Extraction Kit market with a 44% share of global revenue in 2025, supported by a mature immunology treatment ecosystem, deep clinical-research infrastructure, broad payer coverage of biologics, FDA regulatory clarity, and the largest concentration of leading immunology manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the pacemaker/defibrillator lead extraction kit market?
The principal drivers are the rising global burden of cardiac implantable electronic devices; increasing incidence of CIED-related infections, affecting approximately 1.1% of device recipients; growing preference for minimally invasive percutaneous extraction over surgical approaches; continued technological advancement in mechanical and powered extraction tools; rising lead advisories, recalls, and device upgrades; and strengthening clinical guidelines standardizing extraction practice.
Q5. Who are the major players in the pacemaker/defibrillator lead extraction kit market?
The major players include Koninklijke Philips N.V., Cook Medical, and INVAMED, among other active providers profiled in the Competitive Landscape section, along with clinical-stage innovator Xtrac O.S. (Pipeline). Koninklijke Philips N.V. and Cook Medical lead through long-standing clinical evidence and broad, globally distributed extraction tool portfolios.
For illustrative purposes, only a few limited companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.